A carregar...

A Computational Approach for Prioritizing Selection of Therapies Targeting Drug Resistant Variation in Anaplastic Lymphoma Kinase

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase implicated as a driver of a number of cancer types, and activates cellular pathways involved in cell proliferation and differentiation. Tyrosine kinase inhibitors (TKIs) are a small molecule therapeutic that blocks ALK function, but tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AMIA Jt Summits Transl Sci Proc
Main Authors: McCoy, Matthew D., Madhavan, Subha
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Informatics Association 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961773/
https://ncbi.nlm.nih.gov/pubmed/29888064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!